Press Releases
Hetero announces the approval and launch of first generic COVIFOR in India for the treatment of Covid-19
Hetero, one of India’s leading generic pharmaceutical companies, announced that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’...
News
OpenCell Technologies Appoints CEO
OpenCell Technologies, an R&D-stage biomedical venture, has appointed Kevin Gutshall as chief executive officer to lead efforts to translate and commercialize its core technology...
Clinical Trials
PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19
PTC Therapeutics, Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2/3 trial to investigate PTC299, a dihydroorotate dehydrogenase (DHODH)...
Drug Research
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech. The immunotherapy biotech company...
Press Releases
Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19
In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir...
News
Bristol Myers Squibbs CIO joins Quick Base Board of Directors
Quick Base Names 2nd Fortune 500 CIO to Board of Directors, Expanding Bench of Enterprise Leaders Advocating for Citizen Development
Quick Base, the leading low-code...
IT & Data Management
Thermo Fisher Scientific to host Virtual LCMS Conference introducing Orbitrap technology for Asia Pacific region
Thermo Fisher Scientific, the world leader in serving science, announced its upcoming virtual (vLCMS) Conference- An exclusive event focused on state-of-the-art mass spectrometry with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read